Zheng, B., Kurdi, A., Amstutz, A., Green, A., Herrett, E., Tazare, J., Wen, Q., Mahalingasivam, V., Smith, R., MacKenna, B., Mehrkar, A., Bacon, S., Goldacre, B., Robertson, C., Sheikh, S. A., Tomlinson, L. (2026). Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland. Nature Communications. https://doi.org/10.1038/s41467-026-73134-9